公司形象

ABOUT US

We are a multinational corporation specializing in the global commercialization of biotechnology healthcare products, headquartered in Hong Kong. The Group is a professional promoter of innovative medical products, committed to translating cutting-edge biotechnology into medical products and solutions. We are expanding our global distribution network across key markets including Hong Kong, Asian countries, and EU countries, delivering innovative biotech medical products and solutions to government medical institutions, health examination centers, insurance companies, corporate groups, and home users.

Currently, the Group is focused on expanding the global distribution network for its first authorized product - the Test-Reagent for 5-hydroxyindoleacetic acid (Qualitative Colorimetric Method) (used in early screening of multiple cancers*), and commercializing the product in global markets. With core strengths in professional distribution networks, compliant warehousing and logistics, and localized technical support, we drive the development of global healthcare.

* Note: Test results must be comprehensively evaluated alongside clinical examinations and should not be used as a basis for cancer diagnosis. For details regarding the product's sensitivity in detecting certain tumors and cancers, please refer to Section 1 of the "Special Attention and Disclaimer" on this website.

OUR PRODUCT

企業解決方案
Test-Reagent for 5-Hydroxyindoleacetic Acid (Qualitative Colorimetric Method)

Designed for the qualitative detection of 5-Hydroxyindoleacetic Acid (“5-HIAA”) in morning urine. 5-HIAA is a biomarker of abnormal amino acid metabolism caused by cellular irregularities (such as inflammation or stress responses). Through a characteristic color reaction, it enables rapid preliminary screening of metabolic abnormalities, aiding in the identification of potential health risks. Clinical studies demonstrate detection sensitivity for certain tumors and cancers* (including Colorectal Cancer, Gastric Cancer, Breast Cancer, Esophageal Cancer, and Liver Cancer, as well as Gynecological and Other Tumors).